We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Vitamin D Lowers Risk of Atherosclerosis in Diabetes Patients

By LabMedica International staff writers
Posted on 02 Sep 2009
Increased levels of vitamin D may help protect patients with type 2 diabetes from developing coronary vascular diseases such as atherosclerosis.

Vitamin D deficiency is associated with an increased risk of cardiovascular disease in patients with type 2 diabetes. More...
To determine the mechanism that causes accelerated cardiovascular disease in these patients, investigators from Washington University School of Medicine (St. Louis, MO, USA) studied the effects of active vitamin D on macrophage cholesterol deposition. Macrophages can become engorged on cholesterol by engulfing oxidized forms of LDL (low-density lipoproteins). A large excess of cholesterol causes the macrophages to transform into foam cells, which are an integral feature of atherosclerotic plaques.

The investigators worked with cultures of macrophages obtained from five different population groups: obese, diabetic, hypertensive patients with vitamin D deficiency; obese, diabetic, hypertensive patients with normal vitamin D; obese, nondiabetic, hypertensive patients with vitamin D deficiency; nonobese, nondiabetic, nonhypertensive patients with vitamin D deficiency; and nonobese, nondiabetic, nonhypertensive patients with normal vitamin D. The cultures were grown with either vitamin D-deficient or vitamin D-enriched growth media that were supplemented with oxidized LDL.

Results published in the August 10, 2009, online edition of the journal Circulation revealed that vitamin D suppressed foam cell formation in the cultures from diabetic patients by reducing uptake of oxidized LDL cholesterol. Furthermore, deletion of the vitamin D receptor in macrophages from diabetic patients accelerated foam cell formation.

"Vitamin D inhibits the uptake of cholesterol by cells called macrophages,” explained senior author Dr. Carlos Bernal-Mizrachi, professor of endocrinology at Washington University School of Medicine. "When people are deficient in vitamin D, the macrophage cells eat more cholesterol, and they cannot get rid of it. The macrophages get clogged with cholesterol and become what scientists call foam cells, which are one of the earliest markers of atherosclerosis.”

The investigators believe that maintaining adequate vitamin D levels may slow or reverse the development of atherosclerosis in diabetic patients. "There is debate about whether any amount of sun exposure is safe, so oral vitamin D supplements may work best,” said Dr. Bernal-Mizrachi, "but perhaps if people were exposed to sunlight only for a few minutes at a time--that may be an option, too.”

Related Links:

Washington University School of Medicine




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.